Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Sumitomo Pharma America, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Incyte Corporation
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Karyopharm Therapeutics Inc
Incyte Corporation
Masonic Cancer Center, University of Minnesota
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Milton S. Hershey Medical Center
Masonic Cancer Center, University of Minnesota
Ciusss de L'Est de l'Île de Montréal
University of Michigan Rogel Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Singapore General Hospital
Polyphor Ltd.
Singapore General Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Erlangen-Nürnberg Medical School
National Cancer Institute (NCI)
Asan Medical Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Chroma Therapeutics
Fred Hutchinson Cancer Center